Skip to main content
. 2025 Jun 3;15(6):5188–5203. doi: 10.21037/qims-2024-2751

Table 1. Clinical baseline data of the patients.

Variables All (n=219) Non-MCE (n=152) MCE (n=67) P
Sex 0.522
   Female 96 (43.84) 62 (40.79) 34 (50.75)
   Male 123 (56.16) 90 (59.21) 33 (49.25)
Age (years) 0.655
   ≤49 5 (2.28) 4 (2.63) 1 (1.49)
   50–59 57 (26.03) 36 (23.68) 21 (31.34)
   60–69 53 (24.2) 35 (23.03) 18 (26.87)
   70–79 58 (26.48) 43 (28.29) 15 (22.39)
   ≥80 46 (21.01) 34 (22.37) 12 (17.91)
Smoking >0.999
   No 139 (63.47) 93 (61.18) 46 (68.66)
   Yes 80 (36.53) 59 (38.82) 21 (31.34)
Alcohol 0.523
   No 157 (71.69) 102 (67.11) 55 (82.09)
   Yes 62 (28.31) 50 (32.89) 12 (17.91)
Hypertension 0.172
   No 89 (40.64) 60 (39.47) 29 (43.28)
   Yes 130 (59.36) 92 (60.53) 38 (56.72)
Diabetes 0.692
   No 151 (68.95) 108 (71.05) 43 (64.18)
   Yes 68 (31.05) 44 (28.95) 24 (35.82)
Hyperlipidemia 0.102
   No 159 (72.6) 107 (70.39) 52 (77.61)
   Yes 60 (27.4) 45 (29.61) 15 (22.39)
Atrial fibrillation 0.162
   No 133 (60.73) 97 (63.82) 36 (53.73)
   Yes 86 (39.27) 55 (36.18) 31 (46.27)
Heart failure 0.313
   No 98 (44.75) 83 (54.61) 15 (22.39)
   Yes 121 (55.25) 69 (45.39) 52 (77.61)
HMCAS >0.999
   No 160 (73.06) 126 (82.89) 34 (50.75)
   Yes 59 (26.94) 26 (17.11) 33 (49.25)
Massive stroke 0.823
   No 122 (55.71) 109 (71.71) 13 (19.4)
   Yes 97 (44.29) 43 (28.29) 54 (80.6)
Treatment 0.243
   Non-reperfusion 128 (58.45) 81 (53.29) 47 (70.15)
   IVT 39 (17.81) 32 (21.05) 7 (10.45)
   MT 36 (16.44) 29 (19.08) 7 (10.45)
   IVT with MT 16 (7.30) 10 (6.58) 6 (8.95)
Age, years 69.07 (59.0, 78.0) 69.89 (60.0, 78.25) 67.19 (58.0, 76.0) 0.119
Stroke onset time, h 8.71 (3.0, 12.0) 8.84 (3.0, 12.0) 8.41 (3.0, 11.0) 0.728
NIHSS score 12.97 (8.0, 17.0) 11.84 (7.0, 17.0) 15.54 (12.0, 18.0) <0.001*
Infarct volume, cm3 85.63 (24.41, 123.84) 56.35 (13.61, 84.75) 152.06 (95.6, 180.6) <0.001*
ASPECTS 6.71 (5.0, 8.0) 7.38 (6.0, 9.0) 5.21 (4.0, 7.0) <0.001*

Data are presented as n (%) or median (interquartile range). ASPECTS, Alberta Stroke Program Early Computed Tomography Score; HMCAS, hyperdense middle cerebral artery sign; IVT, intravenous thrombolysis; MCE, patients with malignant cerebral edema; MT, mechanical thrombectomy; NIHSS, National Institutes of Health Stroke Scale; Non-MCE, patients without malignant cerebral edema.